Frederic Ors
Direktor/Vorstandsmitglied bei Consortium Québécois sur la Découverte du Médicament
Ursprung des Netzwerks ersten Grades von Frederic Ors
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
24
| Public Company | Biotechnology | 24 |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.
3
| Non-Profit Organization | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Frederic Ors
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Université Laval | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Memorial University of Newfoundland | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Founder Director/Board Member | |
| Dalhousie University | College/University | Doctorate Degree Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| 9342-8530 QUÉBEC INC. | Medical Specialties | Director/Board Member Independent Dir/Board Member | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Reverb Therapeutics | Director/Board Member | ||
| Premier's Technology Council | General Government | Corporate Officer/Principal | |
Amplitude Ventures
 Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Investment Managers | Private Equity Investor | |
Creatus Biosciences, Inc.
 Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Student Biotechnology Network | Founder | ||
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| University of British Columbia | College/University | Doctorate Degree | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| Qurcan Therapeutics, Inc. | Director/Board Member | ||
| University of Toronto | College/University | Masters Business Admin | |
Public Health Research Institute Center
 Public Health Research Institute Center Medical/Nursing ServicesHealth Services The Public Health Research Institute Center provides biomedical research. The private company is based in Newark, NJ. | Medical/Nursing Services | Director/Board Member | |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Corporate Officer/Principal | |
Xagenic, Inc.
 Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
| Rotman School of Management | College/University | Corporate Officer/Principal | |
CTI Life Sciences Fund LP
 CTI Life Sciences Fund LP Investment ManagersFinance CTI Life Sciences Fund LP invests in high quality emerging life sciences companies located in Canada. The fund targets companies operating in the fields of pharmaceuticals and biotechnology companies. It provides financing for seed, early and development stage capital requirements. It also act as lead investor. | Investment Managers | Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
CFA Society Toronto
 CFA Society Toronto Miscellaneous Commercial ServicesCommercial Services CFA Society Toronto supports the professional and business development of charterholders. It provides member services including educational programs, sponsored events, employment postings, and networking opportunities. The company was founded in 1936 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Corporate Officer/Principal | |
| University of Massachusetts | College/University | Graduate Degree | |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chairman | |
Quebec Blue Cross
 Quebec Blue Cross Multi-Line InsuranceFinance Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada. | Multi-Line Insurance | Director/Board Member | |
| Canada Foundation For Innovation | Investment Trusts/Mutual Funds | Director/Board Member | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chairman | |
| Pirus Biological & Vaccine Consulting | President | ||
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Chairman | |
| ALTIMMUNE, INC. | Biotechnology | Director/Board Member | |
| Hoechst Marion Roussel Canada, Inc. | Chief Tech/Sci/R&D Officer | ||
| McGill University | College/University | Corporate Officer/Principal | |
Tekna Plasma Systems, Inc.
 Tekna Plasma Systems, Inc. Chemicals: SpecialtyProcess Industries Tekna Plasma Systems, Inc. develops, designs and constructs integrated plasma systems. It offers nanoparticle synthesis, coating applications, and powder plasma treatments such as spheroidization and purification for laboratory research and industrial-scale processes. The firm provides spheroidization, nanopowder, deposition and aerospace equipment, nano and spherical powders, powder treatment and logistic options. The company was founded by Maher I. Boulos and Jerzy W. Jurewicz in 1990 and is headquartered in Sherbrooke, Canada. | Chemicals: Specialty | Human Resources Officer | |
| Canada Armed Forces | Sovereign | Chief Tech/Sci/R&D Officer | |
CTI Capital, Inc.
 CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Investment Managers | Private Equity Investor | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member |
Statistik
International
| Kanada | 36 |
| Vereinigte Staaten | 16 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 6 |
| Government | 3 |
Operativ
| Director/Board Member | 113 |
| Corporate Officer/Principal | 55 |
| Independent Dir/Board Member | 35 |
| Chairman | 27 |
| President | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Wade Dawe | 27 |
| Louise Proulx | 25 |
| Julia Gregory | 22 |
| Pierre Labbé | 19 |
| Shermaine Tilley | 17 |
| James Hall | 16 |
| Andrew Sheldon | 14 |
| Wayne Pisano | 14 |
| Ali Tehrani | 13 |
| Markus Warmuth | 11 |
| Max Fehlmann | 9 |
| Alfred A. Smithers | 8 |
| Kyle Kuvalanka | 8 |
| Michael P. Bailey | 7 |
| Jeremy Graff | 7 |
- Börse
- Insiders
- Frederic Ors
- Unternehmensverbindungen
